×
MOTS-C 10mg Research Peptide NAD+ 500mg Research Compound
First Order Offer
RMJS 1,000+ researchers subscribed

Get 10% Off
Your First Order

Purity-verified research compounds with third-party COAs. Fast shipping from Colorado.

Order before 12 PM MST — ships same day
99%+ Purity Secure Checkout COA Verified
No thanks, I'll pay full price No spam. Unsubscribe anytime. For research use only.

You're In!

Check your email for your exclusive 10% discount code.

Shop Now
🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado🚚 FREE SHIPPING on all orders over $150⏱ Order before 12 PM MT — ships the same day🧪 99%+ purity — third-party COA with every batch💳 Pay by Card, Venmo, Zelle, ACH or Cash App🎁 FREE bacteriostatic water with every order📱 Customer care — Text us: (720) 285-5706🌐 Shipped from Denver, Colorado

5-Amino-1MQ Research 2026: NNMT Inhibition and the Future of Metabolic Optimization

In the evolving field of metabolic medicine, the focus is expanding beyond traditional GLP-1 agonists to novel mechanisms of action. One of the most discussed compounds in 2026 is 5-Amino-1MQ (5-amino-1-methylquinolinium iodide). Often grouped with peptides in clinical discussions, 5-Amino-1MQ is actually a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT) [1]. This article examines […]

Vector Team

AOD-9604 Research 2026: Targeted Lipolysis Without Growth Hormone Side Effects

The pursuit of pharmacological interventions for obesity and metabolic syndrome has long focused on Human Growth Hormone (hGH). While hGH is highly effective at burning fat, its clinical use for weight loss is severely limited by adverse side effects, including insulin resistance, edema, and the promotion of unwanted cellular growth. In response to these limitations, […]

Vector Team

MOTS-c: The Mitochondrial-Derived Peptide Revolutionizing Metabolic Research in 2026

For decades, the scientific community viewed mitochondria strictly as the “powerhouses of the cell,” responsible solely for generating ATP. However, recent breakthroughs in molecular biology have revealed that mitochondria also function as critical signaling organelles, communicating directly with the cellular nucleus to regulate metabolism, aging, and energy homeostasis. At the forefront of this discovery is […]

Vector Team

GLP-1 Receptor Agonists in Research: From Semaglutide to Next-Generation Peptides

Disclaimer: All products mentioned in this article are intended strictly for laboratory research and in vitro use only. They are not for human or veterinary consumption, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. The landscape of metabolic research has been fundamentally transformed by the […]

Vector Team

MOTS-c: The Mitochondrial Peptide Redefining Metabolic Research in 2026

For decades, the scientific community viewed mitochondria purely as cellular power plants, responsible solely for generating ATP. However, the discovery of mitochondrial-derived peptides (MDPs) has fundamentally shifted this paradigm. Mitochondria are now recognized as active signaling organelles that communicate with the nucleus to regulate systemic metabolism. At the forefront of this research in 2026 is […]

Vector Team

Retatrutide: The Triple-Agonist Peptide Reshaping Metabolic Research in 2026

The landscape of metabolic peptide research has evolved rapidly from single-receptor targets to complex multi-agonist compounds. While semaglutide and tirzepatide have dominated clinical discussions in recent years, retatrutide has emerged in 2026 as a revolutionary subject of investigation. As a “triple-agonist” peptide, retatrutide targets three distinct hormone pathways simultaneously, demonstrating unprecedented metabolic effects in clinical […]

Vector Team